D.E. Shaw & Co Portfolio holdings
D. E. Shaw & Co., L.P., founded in 1988 by David E. Shaw, a former Columbia University computer science professor, is a New York City-based global investment management firm renowned for pioneering quantitative investing, managing over $70 billion in assets as of late 2024. Starting with $28 million from Paloma Partners and private investors, the firm employs sophisticated mathematical models and proprietary algorithms—initially developed by a team of scientists and programmers—to exploit market anomalies across public and private markets, including equities, fixed income, and alternatives. Headquartered above a Greenwich Village bookstore in its early days, it now boasts over 2,500 employees across offices in North America, Europe, and Asia, led by a seven-member Executive Committee since Shaw stepped back in 2001 to focus on D. E. Shaw Research. Despite setbacks like the 1998 Russia debt crisis and the 2008 financial downturn, the firm has maintained a reputation for analytical rigor, risk management, and innovation, balancing its computational roots with discretionary strategies.
Top Buys
| 1 |
GE Vernova
GEV
|
+$601M |
| 2 |
Walt Disney
DIS
|
+$510M |
| 3 |
Palantir
PLTR
|
+$502M |
| 4 |
Financial Select Sector SPDR Fund
XLF
|
+$490M |
| 5 |
TSMC
TSM
|
+$396M |
Top Sells
| 1 |
Boeing
BA
|
+$967M |
| 2 |
iShares Core S&P 500 ETF
IVV
|
+$951M |
| 3 |
SPDR S&P 500 ETF Trust
SPY
|
+$567M |
| 4 |
Eli Lilly
LLY
|
+$551M |
| 5 |
Arthur J. Gallagher & Co
AJG
|
+$499M |
Sector Composition
| 1 | Technology | 20.32% |
| 2 | Healthcare | 13% |
| 3 | Consumer Discretionary | 12.32% |
| 4 | Financials | 8.62% |
| 5 | Industrials | 7.69% |
| Name | Market Value | Portfolio Weight | Shares or Principal |
Shares Change % | Capital Flow | |
|---|---|---|---|---|---|---|
1026
Opko Health
OPK
$1.14B
| $7.85M | 0.01% |
+4,731,688
| New | +$7.85M |
|
1027
Sally Beauty Holdings
SBH
$1.51B
| $7.85M | 0.01% |
869,519
-477,628
| -35% | -$4.31M |
|
1028
Collegium Pharmaceutical
COLL
$1.23B
| $7.79M | 0.01% |
261,132
+43,319
| +20% | +$1.29M |
|
1029
Replimune Group
REPL
$469M
| $7.77M | 0.01% |
796,580
-175,995
| -18% | -$1.72M |
|
1030
Levi Strauss
LEVI
$8.74B
| $7.75M | 0.01% |
497,275
+246,960
| +99% | +$3.85M |
|
1031
Treace Medical Concepts
TMCI
$470M
| $7.72M | 0.01% |
920,174
-195,652
| -18% | -$1.64M |
|
1032
Vanguard Growth ETF
VUG
$189B
| $7.72M | 0.01% |
+20,806
| New | +$7.72M |
|
1033
Magnolia Oil & Gas
MGY
$4.47B
| $7.71M | 0.01% |
305,260
+49,509
| +19% | +$1.25M |
|
1034
MSCI
MSCI
$45.3B
| $7.71M | 0.01% |
13,628
-15,306
| -53% | -$8.66M |
|
1035
Aramark
ARMK
$10.2B
| $7.67M | 0.01% |
+222,323
| New | +$7.67M |
|
1036
Zebra Technologies
ZBRA
$16.1B
| $7.64M | 0.01% |
27,025
+18,248
| +208% | +$5.16M |
|
1037
DaVita
DVA
$9.53B
| $7.6M | 0.01% |
49,712
-70,124
| -59% | -$10.7M |
|
1038
Mineralys Therapeutics
MLYS
$2.88B
| $7.6M | 0.01% |
+478,430
| New | +$7.6M |
|
1039
Gentherm
THRM
$1.1B
| $7.58M | 0.01% |
283,606
+89,022
| +46% | +$2.38M |
|
1040
Navient
NAVI
$1.31B
| $7.58M | 0.01% |
599,918
-125,326
| -17% | -$1.58M |
|
1041
Smith & Nephew
SNN
$16.7B
| $7.56M | 0.01% |
266,361
+99,774
| +60% | +$2.83M |
|
1042
M/I Homes
MHO
$4.14B
| $7.55M | 0.01% |
66,165
+42,265
| +177% | +$4.83M |
|
1043
Century Communities
CCS
$2.06B
| $7.54M | 0.01% |
112,315
-34,407
| -23% | -$2.31M |
|
1044
Integra LifeSciences
IART
$1.21B
| $7.51M | 0.01% |
341,630
-391,921
| -53% | -$8.62M |
|
1045
Ambev
ABEV
$35.7B
| $7.51M | 0.01% |
3,223,811
+2,752,007
| +583% | +$6.41M |
|
1046
Antero Midstream
AM
$8.85B
| $7.51M | 0.01% |
417,235
+192,909
| +86% | +$3.47M |
|
1047
Integer Holdings
ITGR
$3.65B
| $7.51M | 0.01% |
63,628
+54,112
| +569% | +$6.39M |
|
1048
Ferguson
FERG
$45.3B
| $7.48M | 0.01% |
46,708
-407,848
| -90% | -$65.3M |
|
1049
SolarEdge
SEDG
$1.75B
| $7.46M | 0.01% |
461,136
-1,083,002
| -70% | -$17.5M |
|
1050
Metropolitan Bank Holding Corp
MCB
$823M
| $7.45M | 0.01% |
133,133
+22,514
| +20% | +$1.26M |
|